Screener
Tyra Biosciences, Inc. TYRA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
FAQ
- What is Tyra Biosciences, Inc.'s shares (diluted)?
- Tyra Biosciences, Inc. (TYRA) reported shares (diluted) of 61.7M in Q1 2026.
- How has Tyra Biosciences, Inc.'s shares (diluted) changed year-over-year?
- Tyra Biosciences, Inc.'s shares (diluted) increased by 4.1% year-over-year, from 59.3M to 61.7M.
- What is the long-term trend for Tyra Biosciences, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s shares (diluted) has grown at a 72.0% compound annual growth rate (CAGR), from 27.2M to 238.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Tyra Biosciences, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude